CDKN2A and colorectal carcinoma: This evidence is solid in the case of CRC, in which aberrant hypermethylation has been identified in the promoter regions of essential tumor suppressor genes [92], including CDKN2A (in the promoters p16INK4A and p14ARF) [93,94], MLH1 [95] and APC [96].